EP08.02-162 Tepotinib with an EGFR-Tyrosine Kinase Inhibitor (TKI) in Patients with EGFR-mutant MET-amplified NSCLC: A Case Series

Saved in:

Bibliographic Details
Published in	Journal of thoracic oncology Vol. 17; no. 9; pp. S483 - S484
Main Authors	Le, X., Eisert, A., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Tho, L.M., Ahmad, A., Lam, W.-S., Chik, Y.K.J., Lee, W.C.K., Yang, T.-Y., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Wekken, A.v.d.
Format	Journal Article
Language	English
Published	01.09.2022
Online Access	Get full text

Loading…

More Information
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2022.07.845